GlassScriptPhysician profile
Amber Lawless
NPI 1598370140
$1,092.03
in general payments reported to CMS, 2019-2025
16 companies · $295 in 2025
The $295 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $290 · 2023: $230 · 2024: $277 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $801.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $189.68 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Grifols USA, LLC | $166.03 | 2022 | |
| Glaxosmithkline, LLC. | $138.97 | 2022-2025 | Trelegy Ellipta, Pediarix, Bexsero |
| Astrazeneca Pharmaceuticals LP | $96.63 | 2024-2025 | Breztri, Airsupra |
| Lilly USA, LLC | $84.19 | 2023-2025 | Mounjaro, Zepbound |
| Ars Pharmaceuticals Operations, INC. | $69.27 | 2025 | Neffy |
| Exact Sciences Corporation | $61.85 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Phathom Pharmaceuticals, INC. | $49.41 | 2024 | Voquezna |
| Takeda Pharmaceuticals U.S.A., INC. | $49.06 | 2022-2023 | Trintellix |
| Janssen Pharmaceuticals, INC | $37.57 | 2022 | |
| Intuitive Surgical, INC. | $32.55 | 2024 | |
| Abbvie INC. | $31.09 | 2023-2025 | |
| Pfizer INC. | $30.89 | 2023 | |
| Advanced Oxygen Therapy INC. | $19.99 | 2023 | Topical Oxygen Chamber For Extremities |
| Neurocrine Biosciences, INC. | $19.09 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $15.76 | 2025 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amber Lawless listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.